Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer; A Prospective, Randomized, Open-label, Multicenter Phase 2/3 Trial.
Title: | Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer; A Prospective, Randomized, Open-label, Multicenter Phase 2/3 Trial. |
---|---|
Authors: | Jin-Young Jang, Youngmin Han, Hongeun Lee, Sun-Whe Kim, Wooil Kwon, Kyung-Hun Lee, Do-Youn Oh, Eui Kyu Chie, Seong Ho Choi |
Source: | Annals of Surgery; Aug2018, Vol. 268 Issue 2, p215-222, 8p |
Database: | Complementary Index |
ISSN: | 00034932 |
---|---|
DOI: | 10.1097/SLA.0000000000002705 |
Published in: | Annals of Surgery |
Language: | English |